Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Biochem Pharmacol. 2017 Jul 17;143:53–64. doi: 10.1016/j.bcp.2017.07.014

Table 2.

Steady-state transport function of 15Y mutant P-gp with seventeen fluorescent substrates

Fluorescent substrate % Transport (mean ± SD) Transport efficiency
TMR Chloride 121 ± 5 Full transport (>75%)
BD-Verapamil 116 ± 4
BD-EDA 108 ± 9
TMRE 100 ± 3
DiOC 94 ± 3
BD-Forskolin 93 ± 12
Calcein-AM 88 ± 15
Cell Tracker Orange 83 ± 6
SYTO 13 82 ± 5
Daunorubicin 79 ± 11
BD-Prazosin 71 ± 7 Partial transport (30–75%)
LDS-751 70 ± 11
Rhodamine 123 66 ± 5
Dihydrorhodamine 63 ± 12
BD-Paclitaxel 29 ± 15 Little to no transport (<30%)
NBD-CsA 22 ± 9
BD-Vinblastine No detectable transport

Substrates were grouped into three categories based on their transport level when compared to WT; Full transport (>75%), Partial transport (30–75%), and little to no transport (<30%). The transport assays were carried out as described in the Materials and Methods section, and mean ± SD values are from four or more independent experiments. TMR, tetramethylrhosamine, BD-EDA, Bodipy-FL-4,4-difluoro-5,7-dimethyl-4-bora-3a,4a–diaza-s-indacene-3-propionyl ethylenediamine, hydrochloride. TMRE, tetramethylrhodamine ethyl ester perchlorate. DiOC2, 3,3’-Diethyloxancarbocyanine iodide. Cell tracker orange CMTMR, (5-(and-6)-(((4-chloromethy)benzyol)amino)tetramethylrhodamine). LDS-751, quinolinium, 6-(dimethylamino)-2-[4-[4-(dimethylamino)phenyl]-1-ethyl, perchlorate. NBD-CsA, [N-ε(4-nitrobenzofurzan-7-yl)-d-lys cyclosporine A.